R W Klecker
- Infectious Diseases top 2%
- Oncology top 5%
- Virology top 1%
- Molecular Biology
- Epidemiology top 10%
- Co-authors
- Robert F. OzolsYechiam OstchegaRobert C. YoungRobert E. CunnionJoseph E. ParrilloThomas C. HamiltonJerry M. CollinsEdward P. Gelmann
- Topics
- Drug Transport and Resistance Mechanisms (3 papers)Hepatocellular Carcinoma Treatment and Prognosis (2 papers)Colorectal Cancer Treatments and Studies (2 papers)
- Cited by
- VirologyInfectious DiseasesOncology
- Partner nations
- United States
In The Last Decade
R W Klecker
13 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 634
- Oncology 519
- Virology 478
- Molecular Biology 435
- Epidemiology 273
Countries citing papers authored by R W Klecker
This map shows the geographic impact of R W Klecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R W Klecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R W Klecker more than expected).
Fields of papers citing papers by R W Klecker
This network shows the impact of papers produced by R W Klecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R W Klecker. The network helps show where R W Klecker may publish in the future.
Co-authorship network of co-authors of R W Klecker
This figure shows the co-authorship network connecting the top 25 collaborators of R W Klecker. A scholar is included among the top collaborators of R W Klecker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R W Klecker. R W Klecker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 52 | |
| 3 | 27 | |
| 4 | 79 | |
| 5 | 25 | |
| 6 | 32 | |
| 7 | 24 | |
| 8 | 83 | |
| 9 | 53 | |
| 10 | Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. | 21 |
| 11 | 364 | |
| 12 | ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXbreakdown → | 651 |
| 13 | Phase I-II trial of high dose 5-FU infusion with allopurinol in metastatic colorectal cancer | 2 |
| 14 | Phase I-II trial of N-phosphonacetyl-L-aspartate (PALA) and 5-fluorouracil (5FU) | 1 |
About R W Klecker
R W Klecker is a scholar working on Oncology, Hepatology and Virology, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Virology (478 citations), Infectious Diseases (634 citations) and Oncology (519 citations). R W Klecker has collaborated with scholars based in United States. Frequent co-authors include Robert F. Ozols, Yechiam Ostchega, Robert C. Young, Robert E. Cunnion, Joseph E. Parrillo, Thomas C. Hamilton, Jerry M. Collins, Edward P. Gelmann, G M Shearer and Robert Yarchoan. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.